Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors

被引:74
|
作者
Mathew, Bijo [1 ,2 ]
Haridas, Abitha [3 ]
Ucar, Gulberk [4 ]
Baysal, Ipek [4 ]
Adeniyi, Adebayo A. [5 ]
Soliman, Mahmoud E. S. [5 ]
Joy, Monu [6 ]
Mathew, Githa Elizabeth [7 ]
Lakshmanan, Baskar [3 ]
Jayaprakash, Venkatesan [8 ]
机构
[1] Ahalia Sch Pharm, Div Drug Design, Palakkad 678557, Kerala, India
[2] Ahalia Sch Pharm, Med Chem Res Lab, Dept Pharmaceut Chem, Palakkad 678557, Kerala, India
[3] Grace Coll Pharm, Dept Pharmaceut Chem, Palakkad 678004, Kerala, India
[4] Hacettepe Univ, Dept Biochem, Fac Pharm, TR-06100 Ankara, Turkey
[5] Univ KwaZulu Natal, Sch Hlth Sci, ZA-4001 Durban, South Africa
[6] MG Univ, Sch Pure & Appl Phys, Kottayam, Kerala, India
[7] Grace Coll Pharm, Dept Pharmacol, Palakkad 678004, Kerala, India
[8] Birla Inst Technol, Dept Pharmaceut Sci & Technol, Ranchi 835215, Jharkhand, India
关键词
Thienyl chalcones; Human monoamine oxidase; Molecular docking; Molecular dynamics; ACCELERATED MOLECULAR-DYNAMICS; CURCUMIN-BASED DESIGN;
D O I
10.1016/j.ijbiomac.2016.05.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chalcone has been reported to be a valid scaffold for the design of monoamine oxidase (MAO) inhibitors. This scenario has amplified the momentum for the discovery of heteroaryl based chalcone MAO inhibitors. In the present study, we have synthesized a series of eleven chlorinated thienyl chalcone derivatives substituted with a different functional groups at the para- position on the ring B and investigated for their ability to inhibit human MAO-A and-B. With the exception of compound (2E)-1-(4-chlorocyclopental,3-dien-1-yl)-3-(4-nitrophenyl)prop-2-en-1-one (TC7), which was a selective MAO-A inhibitor, all the other derivatives inhibited hMAO-B potently and selectively with competitive mode of inhibition. The most potent compound (2E)-1-(4-chlorocyclopenta-1,3-dien-1-yl)-3-(4-ethylphenyl)prop-2-en-1-one (TC6) was found to be the best activity and higher selectivity towards hMAO-B with Ki and SI values of 0.31 +/- 0.02 mu M and 16.84, respectively. All the compounds presented in the current study are completely non-toxic with 74-88% viable cells to hepatic cells at 100 M concentration. Molecular docking and molecular dynamics simulation studies were carried out using Autodock-4.2 and Amber 14 to understand the molecular level interaction and energy relation of MAO isoforms with selective MAO-B inhibitor TC6. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:680 / 695
页数:16
相关论文
共 50 条
  • [31] CHRONIC EFFECTS OF MONOAMINE OXIDASE-B INHIBITORS ON THE BEHAVIOR OF AGED MICE
    BARBER, AJ
    YU, PH
    BOULTON, AA
    LIFE SCIENCES, 1993, 53 (09) : 739 - 747
  • [32] Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease
    Daphne Robakis
    Stanley Fahn
    CNS Drugs, 2015, 29 : 433 - 441
  • [33] SELECTIVE INHIBITORS OF MONOAMINE OXIDASE-A AND OXIDASE-B - BIOCHEMICAL, PHARMACOLOGICAL, AND CLINICAL PROPERTIES
    FOWLER, CJ
    ROSS, SB
    MEDICINAL RESEARCH REVIEWS, 1984, 4 (03) : 323 - 358
  • [34] ALIPHATIC PROPARGYLAMINES - POTENT, SELECTIVE, IRREVERSIBLE MONOAMINE OXIDASE-B INHIBITORS
    YU, PH
    DAVIS, BA
    BOULTON, AA
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (20) : 3705 - 3713
  • [35] Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update
    Tripathi, Rati Kailash Prasad
    Ayyannan, Senthil Raja
    MEDICINAL RESEARCH REVIEWS, 2019, 39 (05) : 1603 - 1706
  • [36] NEURO-PHARMACOLOGICAL STUDIES ON SELECTIVE MONOAMINE OXIDASE-A AND OXIDASE-B INHIBITORS
    MUKHOPADHYAY, M
    UPADHYAY, SN
    BHATTACHARYA, SK
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 1987, 25 (11) : 761 - 770
  • [37] STRUCTURE-MODULATED RECOGNITION OF SUBSTRATES AND INHIBITORS BY MONOAMINE OXIDASE-A AND OXIDASE-B
    DOSTERT, P
    BENEDETTI, MS
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (01) : 207 - 211
  • [38] Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease
    Robakis, Daphne
    Fahn, Stanley
    CNS DRUGS, 2015, 29 (06) : 433 - 441
  • [39] Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease
    Mathew, Githa Elizabeth
    Oh, Jong Min
    Mohan, Kumar
    Tengli, Anandkumar
    Mathew, Bijo
    Kim, Hoon
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (13): : 4786 - 4794
  • [40] Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study
    Parambi, Della Grace Thomas
    Oh, Jong Min
    Kumar, Sunil
    Sudevan, Sachithra Thazhathuveedu
    Hendawy, Omnia Magdy
    Abdelgawad, Mohamed A.
    Musa, Arafa
    Al-Sanea, Mohammad M.
    Ahmad, Iqrar
    Patel, Harun
    Kim, Hoon
    Mathew, Bijo
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2023, 105